Browse by Departments, Units and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Item Type | Date | Creators | No Grouping
A | B | C | D | E | F | G | J | K | L | M | O | P | R | S | T | U | W | Y
Number of items at this level: 85.


Antonakopoulos, G., Turton, J.A., Whitfield, P. and Newman, J. (1991) Host-parasite interface of the urinary bladder-inhabiting nematode Trichsomoides crassicauda:changes induced in the urothelium of infected rats. International Journal for Parasitology, 21 (2). pp. 187-193. 10.1016/0020-7519(91)90009-V .

Andrews, C.M., Spurling, N.W. and Turton, J.A. (1993) Characterisation of busulphan-induced myelotoxicity in B6C3F1 mice using flow cytometry. Comparative Haematology International, 3 (2). pp. 102-115. 10.1007/BF00368113.

Andrews, C.M., Dash, L.M., Williams, T.C., Craig Gray, J. and Turton, J.A. (1997) Long-term effects of busulphan on lymphocyte subpopulations in female B6C3F1 mice. Comparative Haematology International, 7 (4). pp. 230-237. 10.1007/BF02658695.

Arunothayanun, P., Turton, J.A., Uchegbu, I.F. and Florence, A.T. (1999) Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH) loaded polyhedral and spherical/tubular niosomes. Journal of Pharmaceutical Sciences, 88 (1). pp. 34-38. 10.1021/js980286u.

Arunothayanun, P., Uchegbu, I.F., Craig, D.Q.M., Turton, J.A. and Florence, A.T. (1999) In Vitro/in vivo characterisation of polyhedral niosomes. International Journal of Pharmaceutics, 183 (1). pp. 57-61. 10.1016/S0378-5173(99)00044-7.

Al-Jamal, K.T., Al-Jamal, W.T., Akerman, S., Podesta, J.E., Yilmazer, A., Turton, J.A., Bianco, A., Vargesson, N., Kanthou, C., Florence, A.T., Tozer, G.M. and Kostarelos, K. (2010) Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Proceedings of the National Academy of Sciences of the USA, 107 (9). pp. 3966-3971. 10.1073/pnas.0908401107 .


Brady, S., York, M., Scudamore, C., Williams, T., Griffiths, W.J. and Turton, J.A. (2010) Cardiac troponin I in isoproterenol-induced cardiac injury in the Hanover Wistar rat; studies on low dose levels and routes of administration. Toxicologic Pathology . 10.1177/0192623309357948.


Casadevall, M. and Kortenkamp, A. (1994) The generation of apurinic/apyrimidinic sites in isolated DNA during the reduction of chromate by glutathione. Carcinogenesis, 15 (2). pp. 407-409. 10.1093/carcin/15.2.407.

Casadevall, M., da Cruz Fresco, P. and Kortenkamp, A. (1999) Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites. Chemico-Biological Interactions, 123 (2). pp. 117-132. 10.1016/S0009-2797(99)00128-3.

Cristofori, P., Lanzoni, A., Gaviraghi, G., Turton, J.A. and Sbarbati, A. (2000) Anti-atherosclerotic activity of the calcium antagonist lacidipine in cholesterol fed hamsters. Biomedicine and Pharmacotherapy, 54 (2). pp. 93-99. 10.1016/S0753-3322(00)88858-7.

Cristofori, P., Lanzoni, A., Quartaroli, M., Pastorino, A.M., Zancanaro, C., Cominacini, L., Gaviraghi, G. and Turton, J.A. (2000) The calcium channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse. Journal of Hypertension, 18 (10). pp. 1429-1436.

Cristofori, P., Compagnola, M., Fratta Pasini, A., Garbin, U., Rigoni, A., Tosetti, M., Turton, J.A., Crivellente, F., Munaro, S. and Cominacini, L. (2004) Reduced progression of atherosclerosis in apolipoprotein E-deficient mince treated with lacidipine is associated with decreased susceptibility of low density lipoprotein to oxidation. International Journal of Experimental Pathology, 85 (2). pp. 105-114. 10.1111/j.0959-9673.2004.00375.x.


da Cruz Fresco, P. and Kortenkamp, A. (1994) The formation of DNA cleaving species during the reduction of chromate by ascorbate. Carcinogenesis, 15 (9). pp. 1773-1778. 10.1093/carcin/15.9.1773 .

da Cruz Fresco, P., Shacker, F. and Kortenkamp, A. (1995) The reductive conversion of chromium (VI) by ascorbate gives rise to apurinic/apyrimidinic sites in isolated DNA. Chemical Research in Toxicology, 8 (6). pp. 884-890. 10.1021/tx00048a009.

Dare, T.O., Davies, H.A., Turton, J.A., Lomas, L., Williams, T.C. and York, M.J. (2002) Application of Surface-Enhanced Laser Desorption/Ionization technology to the detection and identification of urinary parvalbumin alpha: a biomarker of compound-induced skeletal muscle toxicity in the rat. Electrophoresis, 23 (18). pp. 3241-3251. 10.1002/1522-2683(200209)23:18<3241::AID-ELPS3241>3.0.CO;2-D.

Duchesne, L., Wells, G., Fernig, D.G., Harris, S.A. and Levy, R. (2008) Supramolecular domains in mixed peptide self-assembled monolayers on gold nanoparticles. ChemBioChem, 9 (7). 10.1002/cbic.200800326.


Ermler, S., Scholze, M. and Kortenkamp, A. (2010) The sensitivity of the MDA-kb2 cell in vitro assay in detecting anti-androgenic chemicals - identification of sources of variability and estimation of statistical power. Toxicology in Vitro, 24 (6). pp. 1845-1853. 10.1016/j.tiv.2010.05.007 .

Evans, R.M., Rahte, S. and Kortenkamp, A. (2010) Inability to confirm estrogenicity of the heterocyclic amine PhIP in two in vitro assays. Toxicology in Vitro, 24 (6). pp. 1757-1763. 10.1016/j.tiv.2009.12.017 .


Festing, M.F.W., Diamanti, P. and Turton, J.A. (2001) Strain differences in haematological response to chloramphenicol succinate in mice: implications for toxicological research. Food and Chemical Toxicology, 39 (4). pp. 375-383. 10.1016/S0278-6915(00)00149-6 .


Gibson, F.M., Andrews, C.M., Diamanti, P., Macharia, G., Gordon-Smith, E.C., Williams, T. and Turton, J.A. (2003) A new model of drug-induced chronic bone marrow aplasia in the busulphan-treated mouse. International Journal of Experimental Pathology, 84 (1). pp. 31-47. 10.1046/j.1365-2613.2003.00239.x.


Jones, C. and Kortenkamp, A. (2000) RAPD library fingerprinting of bacterial and human DNA: applications in mutation detection. Teratogenesis, Carcinogenesis, and Mutagenesis, 20 (2). pp. 49-63. 10.1002/(SICI)1520-6866(2000)20:2<49::AID-TCM1>3.0.CO;2-D.


Kortenkamp, A., Curran, B. and O'Brien, P. (1992) Defining conditions for the efficient in vitro cross-linking of proteins to DNA by chromium(III) compounds. Carcinogenesis, 13 (2). pp. 307-308.

Kortenkamp, A. and O'Brien, P. (1994) The generation of DNA single-strand breaks during the reduction of chromate by ascorbic acid and/or glutathione in vitro. Environmental Health Perspectives, 102 Suppl 3 . pp. 237-241.

Kortenkamp, A., Casadevall, M., Faux, S.P., Jenner, A., Shayer, R.O., Woodbridge, N. and O'Brien, P. (1996) A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione. Archives of Biochemistry and Biophysics, 329 (2). pp. 199-207. 10.1006/abbi.1996.0209.

Kortenkamp, A. (1996) Pharmacokinetic modelling in chromium risk assessment. Human and Experimental Toxicology, 15 (7). pp. 601-602.

Kortenkamp, A., Jones, C. and Baker, J. (1997) Genotypic selection of mutated DNA sequences using mismatch cleavage analysis, a possible basis for novel mutation assays. Mutagenesis, 12 (5). pp. 335-338. 10.1093/mutage/12.5.335.

Kortenkamp, A. and Altenburger, R. (1998) Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles. Science of the Total Environment, 221 (1). pp. 59-73. 10.1016/S0048-9697(98)00261-7.

Kortenkamp, A. and Altenburger, R. (1999) Approaches to assessing combination effects of oestrogenic environmental pollutants. Science of the Total Environment, 233 (1-3). pp. 131-140. 10.1016/S0048-9697(99)00228-4.

Kortenkamp, A. (2006) Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective. International Journal Of Andrology, 29 (1). pp. 193-198. 10.1111/j.1365-2605.2005.00613.x.

Kortenkamp, A. (2007) Introduction: Endocrine Disruptors-Exposure Assessment, Novel End Points, and Low-Dose and Mixture Effects. Environmental Health Perspectives, 115 (S-1). p. 7. 10.1289/ehp.10517..

Karu, K., Hornshaw, M., Woffendin, G., Bodin, K., Hamberg, M., Alvelius, G., Sjovall, J., Turton, J.A., Wang, Y. and Griffiths, W.J. (2007) Liquid chromatography-mass spectrometry utilising multi-stage fragmentation for the identification of oxysterols. Journal of Lipid Research, 48 . pp. 976-987. 10.1194/jlr.M600497-JLR200.

Kortenkamp, A., Faust, M., Scholze, M. and Backhaus, T. (2007) Low-level exposure to multiple chemicals: reason for human health concerns? Environmental Health Perspectives, 115 (Suppl 1). pp. 106-114. 10.1289/ehp.9358..

Kortenkamp, A. (2007) Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environmental Health Perspectives, 115 (Suppl 1). pp. 98-105. 10.1289/ehp.9357.

Kortenkamp, A. (2008) Breast cancer and environmental risk factors: an appraisal of the scientific evidence. Breast Cancer Research, 10 (Suppl 2). P45. 10.1186/bcr1929.

Kabil, A., Silva, E. and Kortenkamp, A. (2008) Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals. Carcinogenesis, 29 (10). pp. 1862-1868. 10.1093/carcin/bgn138.

Kortenkamp, A. (2008) Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. International Journal Of Andrology, 31 (2). pp. 233-240. 10.1111/j.1365-2605.2007.00862.x.

Kortenkamp, A. and Faust, M. (2010) Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment. International Journal Of Andrology, 33 (2). pp. 463-474. 10.1111/j.1365-2605.2009.01047.x.

Kortenkamp, A. (2011) Are cadmium and other heavy metal compounds acting as endocrine disrupters? Metal Ions in Life Sciences, 8 . pp. 305-317.

Karu, K., Turton, J.A., Wang, Y. and Griffiths, W.J. (2011) Nano-liquid chromatography-tandem mass spectrometry analysis of oxysterols in brain: monitoring of cholesterol autoxidation. Chemistry and Physics of Lipids . 10.1016/j.chemphyslip.2011.04.011.


Lacerda, L., Soundararajan, A., Singh, R., Pastorin, G., Al-Jamal, K.T., Turton, J.A., Fredrik, P., Herrero, M.A., Liu, S., Bao, A., Emfietzoglou, D., Mather, S.J., Phillips, W.T., Prato, M., Bianco, A., Goins, B. and Kostarelos, K. (2008) Dynamic imaging of functionalized multi-walled carbon nanotube systemic circulation and urinary excretion. Advanced Materials, 20 (2). pp. 225-230. 10.1002/adma.200890002.


Molyneux, G., Gibson, F.M., Rizzo, S., Sulsh, S., Andrews, C.M., Pilling, A.M., Nakshbandi, T., Gordon-Smith, E.C. and Turton, J.A. (2004) Myelotoxicity of chlorambucil in the Wistar Han rat with particular reference to bone marrow culture, marrow cell apoptosis and levels of Flt-3 ligand. Comparative Clinical Pathology, 13 (2). pp. 70-81. 10.1007/s00580-004-0524-4.

Molyneux, G., Gibson, F.M., Gordon-Smith, E.C., Pilling, A.M., Liu, K.C., Rizzo, S., Sulsh, S. and Turton, J.A. (2005) The haemotoxicity of mitomycin in a repeat dose study inthe female CD-1 mouse. International Journal of Experimental Pathology, 86 (6). pp. 415-430. 10.1111/j.0959-9673.2005.00452.x.

Molyneux, G., Gibson, F.M., Whayman, M. and Turton, J.A. (2008) Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse. International Journal of Experimental Pathology, 89 (2). pp. 159-158. 10.1111/j.1365-2613.2008.00580.x.

Molyneux, G., Gibson, F.M., Chen, C.M., Marway, H.K., McKeag, S., Mifsud, C.V.J., Pilling, A.M., Whayman, M.J. and Turton, J.A. (2008) The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse. International Journal of Experimental Pathology, 89 (2). pp. 138-158. 10.1111/j.1365-2613.2008.00575.x.

Molyneux, G., Rizzo, S., Turton, J.A., Phul, P. and Gibson, F.M. (2009) Near-optimal conditions for the in vitro culture of hemopoietic progenitor cels in bone marrow from the rat. Toxicologic Pathology, 37 (2). pp. 170-174. 10.1177/0192623308328133.

Molyneux, G., Andrews, M., Sones, W.R., York, M.J., Barnett, A., Quirk, E., Yeung, W. and Turton, J.A. (2010) Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration. Cell Biology and Toxicology, 27 (1). pp. 13-40. 10.1007/s10565-010-9167-1.

Modarai, M., Silva, E., Suter, A., Heinrich, M. and Kortenkamp, A. (2011) Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides do not Induce CYP3A4 mRNA Expression. Evidence-Based Complementary and Alternative Medicine, 2011 (213021.). 10.1093/ecam/nep174..

Modarai, M., Suter, A., Kortenkamp, A. and Heinrich, M. (2011) The interaction potential of herbal medicinal prodicts: a luminescence-based screening platform assessing effects on cytochrome P-450 and its use with Devil's Claw (Harpagophyti radix) preparations. Journal of Pharmacy and Pharmacology, 63 (3). pp. 429-438. 10.1111/j.2042-7158.2010.01235.x.


Orton, F., Rosivatz, E., Scholze, M. and Kortenkamp, A. (2011) Widely used pesticides with previously unknown endocrine activity revealed as in vitro antiandrogens. Environmental Health Perspectives, 119 (6). pp. 794-800. 10.1289/ehp.1002895.


Pilling, A.M., Mifsud, N.A.M., Jones, S.A., Endersby-Wood, H.J. and Turton, J.A. (1999) Expression of surfactant protein mRNA in normal and neoplastic lung of B6C3F1 mice as demonstrated by in situ hybridization. Veterinary Pathology, 36 . pp. 57-63. 10.1354/vp.36-1-57 .

Payne, J, Jones, C, Lakhani, S and Kortenkamp, A. (2000) Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens. Science of the Total Environment, 248 (1). pp. 51-62. 10.1016/S0048-9697(99)00479-9.

Payne, J., Rajapakse, N., Wilkins, M. and Kortenkamp, A. (2000) Prediction and assessment of the effects of mixtures of four xenoestrogens. Environmental Health Perspectives, 108 (10). pp. 983-987.

Payne, J., Scholze, M. and Kortenkamp, A. (2001) Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environmental Health Perspectives, 109 (4). pp. 391-397.

Pilling, A.M., Jones, S.A. and Turton, J.A. (2004) Expression of somatostatin mRNA and peptides in C-cell tumours of the thyroid gland in Han Wistar rats. International Journal of Experimental Pathology, 85 (1). pp. 13-23. 10.1111/j.0959-9673.2004.00367.x.

Pilling, A.M., Jones, S.A., Endersby-Wood, H.J., McCormack, N.A.M. and Turton, J.A. (2007) Expression of thyroglobulin and calcitonin in spontaneous thyroid gland tumors in the Han Wistar rat. Toxicologic Pathology, 35 (3). pp. 348-355. 10.1080/01926230701230270.

Pearse, G., Pietersma, A., Cunliffe, H., Foster, J.R., Turton, J.A., Derbyshire, N. and Randall, K.J. (2009) Time-course study of the immunotoxic effects of the anticancer drug chlorambucil in the rat. Toxicologic Pathology, 37 (7). pp. 887-901. 10.1177/0192623309347907.


Rajapakse, N., Ong, D. and Kortenkamp, A. (2001) Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicological Sciences, 60 (2). pp. 296-304. 10.1093/toxsci/60.2.296.

Rajapakse, N., Silva, E. and Kortenkamp, A. (2002) Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environmental Health Perspectives, 110 (9). pp. 917-921.

Rajapakse, N., Silva, E., Scholze, M. and Kortenkamp, A. (2004) Deviation from additivity with estrogenic mixtures containing 4-nonylphenol and 4-tert-octylphenol detected in the E-SCREEN assay. Environmental Science & Technology, 38 (23). pp. 6343-6352. 10.1021/es049681e.

Rajapakse, N., Butterworth, M. and Kortenkamp, A. (2005) Detection of DNA strand breaks and oxidized DNA bases at the single-cell level resulting from exposure to estradiol and hydroxylated metabolites. Environmental and Molecular Mutagenesis, 45 (4). pp. 397-404. 10.1002/em.20104.


Silva, E., Rajapakse, N. and Kortenkamp, A. (2002) Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environmental Science & Technology, 36 (8). pp. 1751-1756. 10.1021/es0101227.

Silva, E., Lopez-Espinosa, M.J., Molina-Molina, J-M., Fernández, M., Olea, N. and Kortenkamp, A. (2006) Lack of activity of cadmium in in vitro estrogenicity assays. Toxicology and Applied Pharmacology, 216 (1). pp. 20-28. 10.1016/j.taap.2006.04.002.

Silva, E., Scholze, M. and Kortenkamp, A. (2007) Activity of xenoestrogens at nanomolar concentrations in the E-Screen assay. Environmental Health Perspectives, 115 Suppl 1 . pp. 91-97. 10.1289/ehp.9363.

Scholze, M. and Kortenkamp, A. (2007) Statistical power considerations show the endocrine disruptor low-dose issue in a new light. Environmental Health Perspectives, 115 (Suppl 1). pp. 84-90. 10.1289/ehp.9364.

Suitthimeathegorn, O., Turton, J.A., Mizuuchi, H. and Florence, A.T. (2007) Intramuscular absorption and biodistribution of dexamethasone from non-aqueous emulsions in the rat. International Journal of Pharmaceutics, 331 (2). pp. 204-210. 10.1016/j.ijpharm.2006.11.062.

Smyth, R., Turton, J.A., Clarke, C.J., York, M.J., Dare, T.O., Lane, C.S. and Munday, M. (2008) Identification of superoxide dismutase as a potential urinary marker of carbon tetrachloride-induced hepatic toxicity. Food and Chemical Toxicology, 46 (9). pp. 2972-2983. 10.1016/j.fct.2008.05.041.

Silva, E., Kabil, A. and Kortenkamp, A. (2010) Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicology and Applied Pharmacology, 245 (2). pp. 160-170. 10.1016/j.taap.2010.02.015 .

Silva, E., Rajapakse, N., Scholze, M., Backhaus, T., Ermler, S. and Kortenkamp, A. (2011) Joint effects of heterogeneous estrogenic chemicals in the E-Screen - exploring the applicability of concentration addition. Toxicological Sciences . 10.1093/toxsci/kfr103.


Turton, J.A., Willars, G.B., Haselden, J.N., Ward, S.J., Steele, C.E. and Hicks, R.A. (1991) Comparative teratogenicity of nine retinoids in the rat. International Journal of Experimental Toxicology, 73 (5). pp. 551-563.

Turton, J.A., Yallop, D., Andrews, C.M., Fagg, R., York, M. and Williams, T.C. (1999) Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover rat. Human and Experimental Toxicology, 18 . pp. 566-576. 10.1191/096032799678845098.

Turton, J.A., Havard, A.C., Robinson, S., Holt, D.E., Andrews, C.M., Fagg, R. and Williams, T.C. (2000) An assessment of chloramphenicol and thiamphenicol in the induction of aplastic anaemia in the BALB/c mouse. Food and Chemical Toxicology, 38 (10). pp. 925-938. 10.1016/S0278-6915(00)00087-9 .

Turton, J.A., Andrews, C.M., Havard, A.C. and Williams, T.C. (2002) Studies on the haemotoxicity of chloramphenicol succinate in the Dunkin Hartley guinea pig. International Journal of Experimental Pathology, 83 (5). pp. 225-238. 10.1046/j.1365-2613.2003.00232.x.

Turton, J.A., Andrews, C.M., Havard, A.C., Robinson, S., York, M., Williams, T. and Gibson, F.M. (2002) Haemotoxicity of thiamphenicol in the BALB/c mouse and Wistar Hanover rat. Food and Chemical Toxicology, 40 (12). pp. 1849-1861. 10.1016/S0278-6915(02)00178-3 .

Turton, J.A., Sones, W.R., Andrews, C.M., Pilling, A.M., Williams, T.C., Molyneux, G., Rizzo, S., Gordon-Smith, E.C. and Gibson, F.M. (2006) Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse. International Journal of Experimental Pathology, 87 (1). pp. 49-63. 10.1111/j.0959-9673.2006.00455.x.

Turton, J.A., Fagg, R., Sones, W.R., Williams, T.C. and Andrews, C.M. (2006) Characterization of the myelotoxicity of chloramphenicol succinate in the B6C3F1 mouse. International Journal of Experimental Pathology, 87 (2). pp. 101-112. 10.1111/j.0959-9673.2006.00460.x.


Uchegbu, I.F., Turton, J.A., Double, J.A. and Florence, A.T. (1994) Drug distribution and a pulmonary adverse effect of intraperitoneally administered doxorubicin niosomes in the mouse. Biopharmaceutics and Drug Disposition, 15 (8). pp. 691-707. 10.1002/bdd.2510150807.

Uchegbu, I.F., Double, J.A., Turton, J.A. and Florence, A.T. (1995) Distrubution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monosterate (Span 60) niosomes in the mouse. Pharmaceutical Research, 12 (7). pp. 1091-1024. 10.1023/A:1016210515134.

Uchegbu, I.F., Double, J.A., Kelland, L.R., Turton, J.A. and Florence, A.T. (1996) The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models. Journal of Drug Targeting, 3 (5). pp. 399-409. 10.3109/10611869608996831 .


Waterfield, C.J., Turton, J.A., Scales, M.D.C. and Timbrell, J.A. (1991) Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride treated rats. Archives of Toxicology, 65 (7). pp. 548-555. 10.1007/BF01973715.

Waterfield, C.J., Turton, J.A., Scales, M.D.C. and Timbrell, J.A. (1993) Reduction of liver taurine in rats by beta-alanine treatment increases carbon tetrachloride toxicity. Toxicology, 77 (1-2). pp. 7-21. 10.1016/0300-483X(93)90133-D.

Waterfield, C.J., Turton, J.A., Scales, M.D.C. and Timbrell, J.A. (1993) The correlation between urinary and liver taurine levels and between pre-dose urinary taurine and liver damage. Toxicology, 77 (1-2). pp. 1-5. 10.1016/0300-483X(93)90132-C .

Waterfield, C.J., Turton, J.A., Scales, M.D.C. and Timbrell, J.A. (1993) Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats. Archives of Toxicology, 67 (4). pp. 244-254. 10.1007/BF01974343.

Waterfield, C.J., Turton, J.A., Scales, M.D.C. and Timbrell, J.A. (1993) Effects of various non-hepatotoxic compounds on urinary and liver taurine levels in rats. Archives of Toxicology, 67 (8). pp. 538-546. 10.1007/BF01969266.


York, M., Scudamore, C., Brady, S., Chen, C., Wilson, S., Curtis, M., Evans, G., Griffiths, W.J., Whayman, M. and Williams, T. (2007) Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat. Toxicologic Pathology, 35 (4). pp. 606-617. 10.1080/01926230701389316.

This list was generated on Wed May 27 21:39:40 2015 BST.